Comparative efficacy and safety of preventive treatment with cytovir-3 and arbidol in children during seasonal outbreak of respiratory viral infection (an open-label randomized clinical study)
Aim: To compare the safety and prophylactic efficacy of Cytovir-3 and Arbidol in an open-label randomized clinical trial in children at seasonal risk of infectious respiratory disease.Methods: This study was performed in the period preceding a seasonal outbreak of acute respiratory viral infections...
Saved in:
Main Authors: | V. S. Smirnov, S. A. Saveliev, S. V. Petlenko, G. Redlich, M. K. Erofeeva, A. V. Lyovina, N. I. Zavialova |
---|---|
Format: | article |
Language: | RU |
Published: |
Sankt-Peterburg : NIIÈM imeni Pastera
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/e2ce4ea93b604997b599b9daa9e85133 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis
by: Behnam Amani, et al.
Published: (2021) -
SUMMARY OF INFLUENZA AND OTHER RESPIRATORY VIRUSES DETECTED AND CHARACTERIZED IN RUSSIA DURING 2017–2018 SEASON
by: A. A. Sominina, et al.
Published: (2018) -
Opportunities for immunocorrection aiming for reduction of morbidity in the areas with adverse occupational and environmental conditions
by: S. V. Petlenko, et al.
Published: (2021) -
Detection of influenza virus and pathogens of acute respiratory viral infections in population of Kazakhstan during 2018-2019 epidemic season
by: N. G. Klivleyeva, et al.
Published: (2021) -
Some opportunities for immunotherapy in coronavirus infection
by: V. S. Smirnov, et al.
Published: (2020)